Verona Pharma Plc (VRNA):企業の財務・戦略的SWOT分析

◆英語タイトル:Verona Pharma Plc (VRNA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH96168FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Verona Pharma Plc (VRNA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Verona Pharma Plc (Verona Pharma) is a clinical-stage biopharmaceutical company that focuses on the development and marketing of therapies for the treatment of respiratory diseases. The company’s lead investigating candidate, ensifentrine, a bronchodilator/anti-inflammatory agent intended for the treatment of chronic obstructive pulmonary disease (COPD) in Phase III clinical trials; additional formulations of ensifentrine for the treatment of COPD: a dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI); in Phase II clinical studies; and ensifentrine in several pre-clinical studies in patients with the novel corona virus (COVID-19). Verona Pharma is headquartered in London, the UK.

Verona Pharma Plc Key Recent Developments

Mar 01,2021: Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference
Feb 18,2021: Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
Nov 23,2020: Verona Pharma secures up to $30 million debt financing from Silicon Valley Bank
Oct 29,2020: Verona Pharma operational update and financial results for the three and nine months ended September 30, 2020
Aug 14,2020: Verona Pharma operational update and financial results for the three and six months ended June 30, 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Verona Pharma Plc – Key Facts
Verona Pharma Plc – Key Employees
Verona Pharma Plc – Key Employee Biographies
Verona Pharma Plc – Major Products and Services
Verona Pharma Plc – History
Verona Pharma Plc – Company Statement
Verona Pharma Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Verona Pharma Plc – Business Description
R&D Overview
Verona Pharma Plc – Corporate Strategy
Verona Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Verona Pharma Plc – Strengths
Verona Pharma Plc – Weaknesses
Verona Pharma Plc – Opportunities
Verona Pharma Plc – Threats
Verona Pharma Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Verona Pharma Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2021: Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference
Feb 18, 2021: Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
Nov 23, 2020: Verona Pharma secures up to $30 million debt financing from Silicon Valley Bank
Oct 29, 2020: Verona Pharma operational update and financial results for the three and nine months ended September 30, 2020
Aug 14, 2020: Verona Pharma operational update and financial results for the three and six months ended June 30, 2020
Apr 08, 2020: Update on AGM Procedure
Feb 27, 2020: Verona Pharma reports financial results for the full year ended December 31, 2019 and Provides Corporate Update
Feb 03, 2020: Verona Pharma announces senior management changes
Jan 07, 2020: Verona Pharma appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Verona Pharma Plc, Key Facts
Verona Pharma Plc, Key Employees
Verona Pharma Plc, Key Employee Biographies
Verona Pharma Plc, Major Products and Services
Verona Pharma Plc, History
Verona Pharma Plc, Subsidiaries
Verona Pharma Plc, Key Competitors
Verona Pharma Plc, Ratios based on current share price
Verona Pharma Plc, Annual Ratios
Verona Pharma Plc, Annual Ratios (Cont...1)
Verona Pharma Plc, Interim Ratios
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Verona Pharma Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Verona Pharma Plc (VRNA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kuwait Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Energy Plc (Kuwait Energy) is an independent oil and gas company that carries out exploration, appraisal, development and production of hydrocarbons. The company operates wide range of oil and gas assets in Middle East and North Africa (MENA) region. It has assets across Egypt, Yemen, …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kotak Wealth Management:企業の戦略・SWOT・財務分析
    Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for di …
  • Duke Energy Ohio Inc:企業の戦略的SWOT分析
    Duke Energy Ohio Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • JSW Steel Ltd:戦略・SWOT・企業財務分析
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brooks Automation Inc (BRKS):企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Empresa Nacional del Petroleo:電力:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Fujita Kanko Inc:企業の戦略・SWOT・財務情報
    Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report Summary Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • 4imprint Group plc (FOUR):企業の財務・戦略的SWOT分析
    4imprint Group plc (FOUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • University of Glasgow-製薬・医療分野:企業M&A・提携分析
    Summary University of Glasgow (UOG) is an educational and research institute that offers undergraduate, post graduate, and online programs. The institute operates through its departments for law, medicine, veterinary medicine and dentistry. It offers courses across various disciplines that include a …
  • Dongwon F&B Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Jumbo SA:企業の戦略・SWOT・財務分析
    Jumbo SA - Strategy, SWOT and Corporate Finance Report Summary Jumbo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Dave & Buster’s Entertainment, Inc.:企業の戦略・SWOT・財務情報
    Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Botswana Power Corporation:企業の戦略的SWOT分析
    Botswana Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Isagen SA ESP:電力:M&Aディール及び事業提携情報
    Summary Isagen SA ESP (Isagen), a subsidiary of BRE Colombia Hydro Investments Limited, is an electricity utility that generates and markets electricity. It also supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sou …
  • MOL Hungarian Oil and Gas Plc (MOL):企業の財務・戦略的SWOT分析
    MOL Hungarian Oil and Gas Plc (MOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stockland Corp Ltd:企業の戦略・SWOT・財務分析
    Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆